Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning
Supportive Care in Cancer · 2026-12 · 34 (12)
DOI: 10.1007/s00520-026-11471-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 18.11.2026. Verfasst von Isabella Gruber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany. i.gruber@ukr.de. Hauptthemen laut MEDLINE: Whole-Body Irradiation, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hematopoietic Stem Cell Transplantation, Stomatitis. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.
Abstract (Originalsprache)
Purpose
We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods
We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more frequently used in older patients and those with a Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) > 3. Multivariable logistic regression assessed factors associated with severe OM, with the Karnofsky Performance Status (KPS) included in the primary model; sensitivity analyses evaluated alternative models.
Results
Severe OM occurred in 48 patients (47.5%) and was more frequent after 12 than 8 Gy (62.0% vs. 33.3%, P = 0.005). In the primary model, 12 Gy TBI was associated with higher odds of severe OM (OR 2.78, 95% CI 1.17–6.78; P = 0.022). The association between 12 Gy TBI and severe OM remained significant when HCT-CI replaced KPS and after calendar-year adjustment. After age adjustment, the estimate was similar, but the confidence interval widened and included the null (OR 2.63, 95% CI 0.90–8.06; P = 0.081). Severe OM was associated with a 4-day longer median hospital stay (41 vs. 37 days, P = 0.001) and a 5-day longer median duration of systemic therapeutic antibiotic treatment (20 vs. 15 days, P = 0.002). Neither measure differed significantly by TBI dose.
Conclusion
Higher TBI dose was associated with severe OM; severe OM was associated with longer hospital stays and systemic therapeutic antibiotic treatment. Findings should be interpreted cautiously given non-randomized TBI allocation. Clinical trial registration This study is a retrospective analysis and was not registered as a clinical trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany. i.gruber@ukr.de.
- Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
- Leibniz Institute for Immunotherapy, Regensburg, Germany.
- Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany.
Förderung
- Universitätsklinikum Regensburg
Zitieren
APA
Gruber, I., Edinger, M., Poeck, H., Meedt, E., Weber, D., Holler, E., Herr, W., Koelbl, O., & Wolff, D. (2026). Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning. Supportive Care in Cancer, 34(12). https://doi.org/10.1007/s00520-026-11471-7
Vancouver
Gruber I, Edinger M, Poeck H, Meedt E, Weber D, Holler E, et al. Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning. Supportive Care in Cancer. 2026;34(12). doi:10.1007/s00520-026-11471-7
BibTeX
@article{Gruber2026,
author = {Gruber, Isabella and Edinger, Matthias and Poeck, Hendrik and Meedt, Elisabeth and Weber, Daniela and Holler, Ernst and Herr, Wolfgang and Koelbl, Oliver and Wolff, Daniel},
title = {Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {12},
doi = {10.1007/s00520-026-11471-7}
}
EUVIMED